Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Imagion Biosystems Ltd. ( (AU:IBX) ) is now available.
Imagion Biosystems Limited has applied to the ASX for quotation of 3,048,484 new fully paid ordinary shares, issued on 8 January 2026 following the exercise of options or conversion of other securities. The additional quotation expands the company’s listed capital base and may modestly enhance liquidity in its shares, signalling ongoing utilisation of existing equity-based instruments and incremental capital formation that could support its operational and development activities.
The most recent analyst rating on (AU:IBX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Imagion Biosystems Ltd. stock, see the AU:IBX Stock Forecast page.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited, listed on the ASX under the code IBX, operates in the healthcare and biotechnology sector, focusing on the development and commercialisation of diagnostic and imaging technologies. The company targets medical applications that aim to improve disease detection and monitoring, positioning itself within the specialised medical imaging and diagnostics market.
Average Trading Volume: 3,570,118
Technical Sentiment Signal: Hold
Current Market Cap: A$14.63M
See more data about IBX stock on TipRanks’ Stock Analysis page.